133 related articles for article (PubMed ID: 8360173)
21. A differential requirement for the COOH-terminal region of the epidermal growth factor (EGF) receptor in amphiregulin and EGF mitogenic signaling.
Wong L; Deb TB; Thompson SA; Wells A; Johnson GR
J Biol Chem; 1999 Mar; 274(13):8900-9. PubMed ID: 10085134
[TBL] [Abstract][Full Text] [Related]
22. Heparin inhibition of autonomous growth implicates amphiregulin as an autocrine growth factor for normal human mammary epithelial cells.
Li S; Plowman GD; Buckley SD; Shipley GD
J Cell Physiol; 1992 Oct; 153(1):103-11. PubMed ID: 1522124
[TBL] [Abstract][Full Text] [Related]
23. Amphiregulin induces tyrosine phosphorylation of the epidermal growth factor receptor and p185erbB2. Evidence that amphiregulin acts exclusively through the epidermal growth factor receptor at the surface of human epithelial cells.
Johnson GR; Kannan B; Shoyab M; Stromberg K
J Biol Chem; 1993 Feb; 268(4):2924-31. PubMed ID: 7679104
[TBL] [Abstract][Full Text] [Related]
24. Epidermal growth factor and amphiregulin up-regulate matrix metalloproteinase-9 (MMP-9) in human breast cancer cells.
Kondapaka SB; Fridman R; Reddy KB
Int J Cancer; 1997 Mar; 70(6):722-6. PubMed ID: 9096655
[TBL] [Abstract][Full Text] [Related]
25. Amphiregulin antisense oligonucleotide inhibits the growth of T3M4 human pancreatic cancer cells and sensitizes the cells to EGF receptor-targeted therapy.
Funatomi H; Itakura J; Ishiwata T; Pastan I; Thompson SA; Johnson GR; Korc M
Int J Cancer; 1997 Jul; 72(3):512-7. PubMed ID: 9247297
[TBL] [Abstract][Full Text] [Related]
26. Epidermal growth factor-related peptides in the pathogenesis of human breast cancer.
Normanno N; Ciardiello F; Brandt R; Salomon DS
Breast Cancer Res Treat; 1994 Jan; 29(1):11-27. PubMed ID: 7912564
[TBL] [Abstract][Full Text] [Related]
27. Amphiregulin acts as an autocrine growth factor in two human polarizing colon cancer lines that exhibit domain selective EGF receptor mitogenesis.
Damstrup L; Kuwada SK; Dempsey PJ; Brown CL; Hawkey CJ; Poulsen HS; Wiley HS; Coffey RJ
Br J Cancer; 1999 Jun; 80(7):1012-9. PubMed ID: 10362109
[TBL] [Abstract][Full Text] [Related]
28. Differential immunohistochemical detection of transforming growth factor alpha, amphiregulin and CRIPTO in human normal and malignant breast tissues.
Panico L; D'Antonio A; Salvatore G; Mezza E; Tortora G; De Laurentiis M; De Placido S; Giordano T; Merino M; Salomon DS; Mullick WJ; Pettinato G; Schnitt SJ; Bianco AR; Ciardiello F
Int J Cancer; 1996 Jan; 65(1):51-6. PubMed ID: 8543395
[TBL] [Abstract][Full Text] [Related]
29. The epidermal growth factor receptor couples transforming growth factor-alpha, heparin-binding epidermal growth factor-like factor, and amphiregulin to Neu, ErbB-3, and ErbB-4.
Riese DJ; Kim ED; Elenius K; Buckley S; Klagsbrun M; Plowman GD; Stern DF
J Biol Chem; 1996 Aug; 271(33):20047-52. PubMed ID: 8702723
[TBL] [Abstract][Full Text] [Related]
30. Purification of amphiregulin from serum-free conditioned medium of 12-O-tetradecanoylphorbol 13-acetate-treated cell lines.
Shoyab M; Plowman GD
Methods Enzymol; 1991; 198():213-21. PubMed ID: 1857220
[No Abstract] [Full Text] [Related]
31. Auto- and cross-induction within the mammalian epidermal growth factor-related peptide family.
Barnard JA; Graves-Deal R; Pittelkow MR; DuBois R; Cook P; Ramsey GW; Bishop PR; Damstrup L; Coffey RJ
J Biol Chem; 1994 Sep; 269(36):22817-22. PubMed ID: 8077234
[TBL] [Abstract][Full Text] [Related]
32. Differential effects of a heparin antagonist (hexadimethrine) or chlorate on amphiregulin, basic fibroblast growth factor, and heparin-binding EGF-like growth factor activity.
Cook PW; Ashton NM; Karkaria CE; Siess DC; Shipley GD
J Cell Physiol; 1995 May; 163(2):418-29. PubMed ID: 7706383
[TBL] [Abstract][Full Text] [Related]
33. Growth factor-independent proliferation of rat mammary carcinoma cells by autocrine secretion of neu-differentiation factor/heregulin and transforming growth factor-alpha.
Ethier SP; Langton BC; Dilts CA
Mol Carcinog; 1996 Feb; 15(2):134-43. PubMed ID: 8599580
[TBL] [Abstract][Full Text] [Related]
34. Altered EGFR localization and degradation in human breast cancer cells with an amphiregulin/EGFR autocrine loop.
Willmarth NE; Baillo A; Dziubinski ML; Wilson K; Riese DJ; Ethier SP
Cell Signal; 2009 Feb; 21(2):212-9. PubMed ID: 18951974
[TBL] [Abstract][Full Text] [Related]
35. Differential regulation of cell proliferation and protease secretion by epidermal growth factor and amphiregulin in tumoral versus normal breast epithelial cells.
Silvy M; Giusti C; Martin PM; Berthois Y
Br J Cancer; 2001 Apr; 84(7):936-45. PubMed ID: 11286474
[TBL] [Abstract][Full Text] [Related]
36. Production of glycosylated heparin-binding EGF-like growth factor in HeLa cells using vaccinia virus.
Davis KM; Brigstock DR; Johnson PR; Crissman-Combs MA; McCarthy DW; Downing MT; Besner GE
Protein Expr Purif; 1996 Aug; 8(1):57-67. PubMed ID: 8812835
[TBL] [Abstract][Full Text] [Related]
37. Expression of amphiregulin in the sheep mammary gland.
Forsyth IA; Taylor JA; Keable S; Turvey A; Lennard S
Mol Cell Endocrinol; 1997 Jan; 126(1):41-8. PubMed ID: 9027362
[TBL] [Abstract][Full Text] [Related]
38. Structure and function of human amphiregulin: a member of the epidermal growth factor family.
Shoyab M; Plowman GD; McDonald VL; Bradley JG; Todaro GJ
Science; 1989 Feb; 243(4894 Pt 1):1074-6. PubMed ID: 2466334
[TBL] [Abstract][Full Text] [Related]
39. A functional screen for genes inducing epidermal growth factor autonomy of human mammary epithelial cells confirms the role of amphiregulin.
Berquin IM; Dziubinski ML; Nolan GP; Ethier SP
Oncogene; 2001 Jul; 20(30):4019-28. PubMed ID: 11494130
[TBL] [Abstract][Full Text] [Related]
40. Expression of transforming growth factor alpha, amphiregulin and cripto-1 in human breast carcinomas.
Qi CF; Liscia DS; Normanno N; Merlo G; Johnson GR; Gullick WJ; Ciardiello F; Saeki T; Brandt R; Kim N
Br J Cancer; 1994 May; 69(5):903-10. PubMed ID: 8180021
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
